Latest other assets for CUE: $13M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Cue Biopharma (CUE) currently reports a other assets of $13M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Cue Biopharma's other assets history and peer comparisons.
Cue Biopharma's other assets changed from $0 to $13M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Cue Biopharma reported $13M in other assets as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other assets of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cue Biopharma, and consider following CUE for alerts when major investors trade the stock.
Cue Biopharma is classified in the Healthcare sector. On other assets, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CUE with unrelated industries.